Neoplasia/BPH

	A Trial-Level Benefit-Toxicity Mapping Framework for Adjuvant Therapy in Renal Cell Carcinoma: A Focused Review. Int J Urol Shinohara M, Narita T, Hatakeyama S. PMID: 42954085 [PubMed - indexed for MEDLINE]
	Histopathological Imaging and Artificial Intelligence for Cancer Diagnosis and Gleason Grading: A Brief Review of Prostate Cancer. J Clin Pract Res Latifo, Han, Bulucu FO. PMID: 42953790 [PubMed]
	Racial Variations in PSA and PSA Density Among Men With Negative Prostate Biopsies: A Multicenter Comparative Study of Chinese, African American, and Caucasian American Populations. Cancer Med Xiong Z, Zhou P, Xu A, Guo C, Xiong S, Tang P. PMID: 42952419 [PubMed - indexed for MEDLINE]
	Opposing roles of acid phosphatase 1 (ACP1) and ACP3 in prostate cancer progression. BJU Int Faria AVS, Ferreira-Halder CV, Peppelenbosch MP, Fuhler GM. PMID: 42952235 [PubMed - as supplied by publisher]
	Identification of ageing-related genes in prostate cancer with type 2 Diabetes using machine learning: a multi-omics study focusing on SOX4, PRNP, and FOXO4. Artif Cells Nanomed Biotechnol Zhang W, Zhang X, Zhang C, Shi X, Deng Y, Gao Y, Bi K, Wang Z, Chen G, Ye Z, An Z, Fu W. PMID: 42952172 [PubMed - indexed for MEDLINE]
	Combined Application of 3D Reconstruction and ICG Fluorescence Imaging in Pelvic Lymph Node Dissection for Bladder Cancer: A Retrospective Study. J Endourol Wei Y, Liu Q, Li S, Jia F, Li J, Hao H, Pang J, Li J, Yan P, Xing Q, Zhang H, He J, Liu C, Yang X. PMID: 42952089 [PubMed - as supplied by publisher]
	PSMA Theranostics for Prostate Cancer: Evidence, Pitfalls, and Implementation in Japan. Int J Urol Hirata K, Watanabe S, Wakabayashi H, Kudo K, Nishie A. PMID: 42952025 [PubMed - indexed for MEDLINE]
	PSMA-directed radioligand therapy and radium-223 in prostate cancer bone metastases. Semin Nucl Med Sathekge M. PMID: 42951717 [PubMed - as supplied by publisher]
	Talazoparib plus enzalutamide versus placebo plus enzalutamide in metastatic androgen pathway modulator-resistant (castration-resistant) prostate cancer (TALAPRO-2): a biomarker analysis of circulating tumour DNA and cells for prognosis and molecular profiling. Lancet Oncol Yip SM, Laird AD, Agarwal N, Zschäbitz S, Fizazi K, Matsubara N, Joung JY, Karsh LI, Carles J, Fay AP, Piulats JM, Fong PCC, Liu G, Albacker LA, Pasquina LW, Chelliserry J, Healy CG, Lin X, Kalac M, Azad AA. PMID: 42950862 [PubMed - as supplied by publisher]
	Intraductal and Cribriform Carcinoma of the Prostate: A Clinical Companion to the GUPS/ISUP Consensus Guidelines. J Urol Weiner AB, Shah RB, Paner GP, Ehdaie B, Eggener SE. PMID: 42949829 [PubMed - as supplied by publisher]
	Machine learning-based classification of renal cell carcinoma and upper tract urothelial carcinoma using preoperative hematological markers. Biomed Rep Nuwatkrisin K, Panwoon C, Senchan K, Sangkhamanon S, Seubwai W. PMID: 42948584 [PubMed]
	Combined Transarterial Embolization and Percutaneous CT-Guided Cryoablation of Renal Cell Carcinoma: A Retrospective Single-Center Study. Cureus Vogl TJ, Recoschewitz C, Cojocaru R, Nica AI, Adwan H. PMID: 42948124 [PubMed]
	Erdi Bazhen decoction for cancer-related fatigue due to qi and blood deficiency in prostate cancer patients receiving androgen deprivation therapy: an exploratory randomized, double-blind, placebo-controlled pilot clinical trial protocol. Front Med (Lausanne) Wei J, Ma J, Ma Z, Liu Y, Xu L, Mei X, Zhang P. PMID: 42947754 [PubMed]
	Predictors of guideline-concordant treatment intensification in metastatic castration-sensitive prostate cancer: an explainable machine learning study. Front Oncol Barton Odro E, Bychinski J, Van Alstyne T, Corsini C, Owen P, Jones CP, Krebs N, Solomon B, Vaca R, Williams C, Elsey R, Meissner T. PMID: 42947672 [PubMed]
	Light Microscopy-Based Techniques to Identify TFEB-Altered Renal Cell Carcinoma: A Comparison Study With TFE3-Rearranged Renal Cell Carcinoma and Common Renal Cell Tumors. Am J Surg Pathol Caliò A, Marletta S, Giacometti C, Pedron S, Bariani E, Brunelli M, Antonini P, Stefanizzi L, Marcolini L, Martignoni G. PMID: 42947507 [PubMed - as supplied by publisher]
	Perioperative tranexamic acid and postoperative haematuria after transvesical prostatectomy: a prospective observational cohort study. BMC Urol Terzi, Milojevi, , Jovanovi, Petrovi, La, Bumba, A, La, Bukumiri. PMID: 42947076 [PubMed - indexed for MEDLINE]
	ASO Author Reflections: (68)Ga-PSMA-11 PET/CT for Renal Cell Carcinoma Tumor Thrombus: Diagnostic Advances and Therapeutic Stratification. Ann Surg Oncol Lin BH, Zeng CL, Wu XH, Gao RC, Qiu QR, Chen YH, Xue XY, Zheng QS, Chen SH, Wei Y, Xu N. PMID: 42946930 [PubMed - as supplied by publisher]
	Focal therapy vs radical prostatectomy for localized prostate cancer: a systematic review, meta-analysis, bayesian network, and trial sequential analysis. Int Urol Nephrol Hinojosa-Gonzalez DE, Slawin B, Torres-Martinez M, Coady PJ, Hernandez BS, Calvillo-Ramirez A, Saffati G, Oppenheimer AG, de Jesus Aguirre-Vera G, Jones JA, Slawin JR. PMID: 42946901 [PubMed - as supplied by publisher]
	Prostate cancer worldwide: updated epidemiology, disparities, and screening implications. Prostate Cancer Prostatic Dis Bernardino RM, Nguyen DD, Carlsson SV, Gandaglia G, Schwen Z, Soputro NA, Watfa M, Al-Bayati A, El Hussein M, Campbell R, Daher K, Younis S, Nguyen J, Weight C, La Vecchia C, Zlotta AR, de Nunzio C, Abdollah F, Shoag JE, Basourakos S, Ferronha F, Cosenza A, Wallis C, Trinh QD, Fleshner N, Kaouk J, Autorino R. PMID: 42946767 [PubMed - as supplied by publisher]
	Overall Survival After Neoadjuvant Versus Adjuvant Chemotherapy for Invasive Urothelial Carcinoma of the Bladder: A Real-world Multicenter Cohort Study. Anticancer Res Chen HW, Li JR, Wang SS, Yang CK, Hsu JY, Chang CC. PMID: 42946419 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 192455

Page 1 of 9623



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy